ongoing

The Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial is a multicenter, international, prospective, blinded, randomized controlled trial to determine effectiveness of left atrial appendage occlusion for the prevention of stroke or systemic arterial embolism in patients undergoing cardiac surgery who have risk factors for atrial fibrillation and stroke.

LeAAPS will enroll 6500 patients globally across the United States, Canada, Europe, Asia Pacific, and other countries to be determined. Patients randomized to left atrial appendage (LAA) exclusion will have their LAA managed using the AtriClip device.

Study Type

Interventional - Device

Study Design

Multicentered, blinded RCT

NO. of Countries

10

NO. of Sites

150

NO. of Participants

6500

Study Period

2023-2032

Sponsor

AtriCure, Inc.

Back To Top